CTI and Harrison Clinical Research Announce a New Collaboration
CTI Clinical Trial and Consulting Services (CTI) and Harrison Clinical Research (HCR) are proud to announce their new collaboration focusing on the expansion of the clinical trial capabilities of both organizations.
Munich, Germany and Cincinnati, Ohio – June 19, 2006 – CTI Clinical Trial and Consulting Services (CTI) and Harrison Clinical Research (HCR) are proud to announce their new collaboration focusing on the expansion of the clinical trial capabilities of both organizations. The collaboration will also include offering global consulting services, such as, but not limited to professional education, healthcare communications and regulatory and drug development planning. The formalized relationship will allow both companies' expanded global exposure to better serve clients at all stages of drug, device and market development.
Francisco Harrison, MD, Chairman of the HCR group said, "We look forward to better leveraging the expertise and rich histories that HCR and CTI offer the pharmaceutical and biotechnology industry. The combination of experienced personnel and therapeutic expertise will afford HCR, CTI and our clients expanded opportunity and prosperity on a global basis."
This collaboration combines services of two successful Clinical Research and Drug Development organizations with similar philosophies and goals aimed at assisting pharmaceutical companies with executing Phase I - IV clinical trials. The combined CTI and HCR clinical research and consulting services will span over three continents including, most significantly, North America, Europe and Asia. There are numerous synergies in their respective therapeutic areas of expertise that will greatly benefit pharmaceutical, biotechnology and device clients.
Driving Diversity with the Integrated Research Model
October 16th 2024Ashley Moultrie, CCRP, senior director, DEI & community engagement, Javara discusses current trends and challenges with achieving greater diversity in clinical trials, how integrated research organizations are bringing care directly to patients, and more.
AI in Clinical Trials: A Long, But Promising Road Ahead
May 29th 2024Stephen Pyke, chief clinical data and digital officer, Parexel, discusses how AI can be used in clinical trials to streamline operational processes, the importance of collaboration and data sharing in advancing the use of technology, and more.
The Rise of Predictive Engagement Tools in Clinical Trials
November 22nd 2024Patient attrition can be a significant barrier to the success of a randomized controlled trial (RCT). Today, with the help of AI-powered predictive engagement tools, clinical study managers are finding ways to proactively reduce attrition rates in RCTs, and increase the effectiveness of their trial. In this guide, we look at the role AI-powered patient engagement tools play in clinical research, from the problems they’re being used to solve to the areas and indications in which they’re being deployed.
